OPKO Health, Inc. SEC Filings INVESTORS SEC FILINGS Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Form 8937 Latest Quarterly or Annual Filing 10-Q October 28, 2021 Quarterly report pursuant to Section 13 or 15(d) Related Documents VIEW PDF VIEW HTML Latest Current Report 8-K October 28, 2021 Current report filing VIEW PDF VIEW HTML Latest Proxy Statement DEF 14A April 30, 2021 Definitive proxy statements VIEW PDF VIEW HTML View All SEC Filings View and filter by group or type VIEW ALL FILINGS Email Alerts Tear Sheet Contacts RSS News Feed © 2021 OPKO Health, Inc. All Rights Reserved. PRIVACY POLICY GOVERNANCE TERMS OF USE SITEMAP

OPKO Health, Inc. Locations North America: OPKO Health (https://www.opko.com) OPKO Renal (http://www.opkorenal.com) BioReference Laboratories (https://www.bioreference.com) GeneDx (https://www.genedx.com) GenPath Oncology (https://www.genpathdiagnostics.com/oncology) GenPath Women's Health (https://www.genpathdiagnostics.com/womens-health) Middle East: OPKO Biologics (https://www.opkobiologics.com) OPKO Finetech (http://www.finetechlab.com) Europe: Eirgen Pharma (https://eirgen.com) OPKO EU (http://www.opkoeurope.com) Latin America: OPKO Chile (http://www.opko.cl) © 2021 OPKO Health, Inc. All Rights Reserved. PRIVACY POLICY GOVERNANCE TERMS OF USE SITEMAP

OPKO Health, Inc. Contact Get In Touch With Us ADDRESS 4400 Biscayne Boulevard Miami, FL 33137 PHONE Tel: 305-575-4100 EMAIL contact@opko.com First Name Last Name Email Comments: SUBMIT © 2021 OPKO Health, Inc. All Rights Reserved. PRIVACY POLICY GOVERNANCE TERMS OF USE SITEMAP

OPKO Health, Inc. Management Team WHO WE ARE OUR LEADERSHIP Management Team Board of Directors Phil Frost CEO and Chairman Jane Hsiao CTO and Vice Chairman Steve Rubin Executive Vice President, Administration Adam Logal Senior Vice President and CFO Jon R. Cohen Senior Vice President, OPKO Health; Executive Chairman, BioReference Laboratories, Director Geoff Monk President, BioReference Laboratories Charles Bishop CEO of OPKO Renal Tony Cruz President of Transition Therapeutics Hans Berner President, OPKO Health Iberoamerica Jane Pine Wood CLO, BioReference Laboratories Damien Burke CEO, Eirgen Pharma Arie Gutman President of API © 2021 OPKO Health, Inc. All Rights Reserved. PRIVACY POLICY GOVERNANCE TERMS OF USE SITEMAP